Dr Amado Bamba Lugue Jr, MD is a
Family Medicine physician based in Pleasant Gap, Pennsylvania. Dr Amado Bamba Lugue Jr is licensed to practice in Pennsylvania (license number MD032224L) and his current practice location is 265 Steeplechase Dr, Pleasant Gap, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at
(814) 359-2199.
NPI number for Dr Amado Bamba Lugue Jr is 1386826865 and his current mailing address is 265 Steeplechase Dr, Pleasant Gap, Pennsylvania. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1386826865.
Physician's Profile
Full Name | Dr Amado Bamba Lugue Jr |
---|
Gender | Male |
---|
Speciality | Family Medicine |
---|
Location | 265 Steeplechase Dr, Pleasant Gap, Pennsylvania |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
NPI Data:
- NPI Number: 1386826865
- Provider Enumeration Date: 11/27/2007
- Last Update Date: 11/27/2007
Medical Identifiers
Medical identifiers for Dr Amado Bamba Lugue Jr such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1386826865 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
207Q00000X | Family Medicine | MD032224L (Pennsylvania) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Amado Bamba Lugue Jr is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Dr Amado Bamba Lugue Jr, MD 265 Steeplechase Dr, Pleasant Gap, PA 16823-9624 Ph: (814) 359-2199 | Dr Amado Bamba Lugue Jr, MD 265 Steeplechase Dr, Pleasant Gap, PA 16823-9624 Ph: (814) 359-2199 |
Reviews and Comments